TG Therapeutics Inc TGTX:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/18/22 EDT
7.31quote price arrow down-0.12 (-1.62%)
Volume
2,013,363
52 week range
3.48 - 35.94
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.31
  • 52 Week High35.94
  • 52 Week High Date11/08/21
  • 52 Week Low3.48
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap1.062B
  • Shares Out145.27M
  • 10 Day Average Volume3.65M
  • Dividend-
  • Dividend Yield-
  • Beta2.31
  • YTD % Change-61.53

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.31
  • 52 Week High35.94
  • 52 Week High Date11/08/21
  • 52 Week Low3.48
  • 52 Week Low Date06/16/22
  • Market Cap1.062B
  • Shares Out145.27M
  • 10 Day Average Volume3.65M
  • Dividend-
  • Dividend Yield-
  • Beta2.31
  • YTD % Change-61.53

RATIOS/PROFITABILITY

  • EPS (TTM)-2.17
  • P/E (TTM)-3.38
  • Fwd P/E (NTM)-4.41
  • EBITDA (TTM)-283.578M
  • ROE (TTM)-112.66%
  • Revenue (TTM)6.96M
  • Gross Margin (TTM)89.05%
  • Net Margin (TTM)-4,144.49%
  • Debt To Equity (MRQ)53.43%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On TG Therapeutics Inc

There is no recent news for this security.

Profile

MORE
TG Therapeutics, Inc. (TG) is a fully integrated, commercial stage biopharmaceutical company, which is focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. Its pipeline candidates include TG-1501 (Cosibelimab), TG-1701 (BTK inhibitor), TG-1801 (anti-CD47/anti-CD19 bispecific monoclonal antibody). Its UKONIQ (umbralisib) is developed for the treatment of adult patients with relapsed or refractory marginal...
Michael Weiss J.D.
Chairman of the Board, President, Chief Executive Officer
Sean Power CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Address
2 Gansevoort Street, 9Th Floor
New York, NY
10014
United States

Top Peers

SYMBOLLASTCHG%CHG
ERAS
Erasca Inc
9.00-0.64-6.64%
RNA
Avidity Biosciences Inc
21.41+0.36+1.71%
MDGL
Madrigal Pharmaceuticals Inc
73.21-1.34-1.80%
RCKT
Rocket Pharmaceuticals Inc
17.34-0.30-1.70%
IGMS
IGM Biosciences Inc
22.73-1.62-6.65%